期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性心肌梗死患者预后与血清脑利钠肽及糖尿病的临床探讨 被引量：5

下载PDF
导出
摘要 心血管疾病是威胁人类健康的重要疾病。对心血管疾病的正确评价非常重要。而心脏生物化学标志物的应用为我们提供了客观依据。本文旨在探讨急性心肌梗死（acute myocardial infarction，AMI）患者预后与血清脑利钠肽及糖尿病的临床关系。
作者 赵海松
机构地区 天津市武清区人民医院心血管内科
出处 《天津医科大学学报》 2008年第3期394-395,400,共3页 Journal of Tianjin Medical University
关键词 急性心肌梗死 脑利钠肽 糖尿病
分类号 R542.22 [医药卫生—心血管疾病] R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献10

  • 1Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans : Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic pepide and brain natriureti peptide[J]. J Clin Invest, 1991,87 (3): 1402
  • 2潘柏申.心脏标志物的临床应用[J].中华检验医学杂志,2005,28(1):124-126. 被引量：62
  • 3Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretie peptide in patients with aeute myoeardial infarction [J]. Circulation, 1993,88(3): 82
  • 4KUHN M. Molecular physiology of natriuretic peptide signaling [J]. Basic Res Cardiol, 2004,99(2):76
  • 5Omland T, Persson A, Ng L, et al. N - terminal pro - B - type natriuretic peptide and long - term mortality in acute coronary syndrnmes [J]. Circulation, 2002,106(5):2913
  • 6Hans K, Mery B. B-type natriuretic pettide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a left ventrieular assist device [J]. Clin Chem, 2004,50(9):1670
  • 7Angeja BG, de Lemos J, Muvphy SA, et al. Impact of diabetes mellituss on epicardial and microvascular flow after fibrinolytic therapy [J]. Am Hert J, 2002, 144(4) :649
  • 8沈絮华,贾三庆,李宏伟.血糖对直接经皮冠状动脉介入治疗后患者心肌灌注的影响[J].中华心血管病杂志,2006,34(2):138-142. 被引量：22
  • 9Werner GS, Richartz BM, Heinke S, et al. Impaired acute collateral recruitment al a possible mechanism for increase cardiac adverse events in patients with diabetes mellitus [J]. Eur Heart J, 2003,24 (12):1134
  • 10Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long - term survival after acute myocardial infarction [J]. Circulation, 1996, 93(3) : 1963

二级参考文献18

  • 1Zijlstra F,Hoorntje JC,de Boer MJ,et al.Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.N Engl J Med,1999,341:1413-1419.
  • 2Waldecker B,Waas W,Haberbosch W,et al.Type 2 diabetes and acute myocardial infarction.Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients.Diabetes Care,1999,22:1832-1838.
  • 3Fava S,Aquilina O,AzzoPardi J,et al.The prognostic value of blood glucose in diabetic patients with acute myocardial infarction.Diabet Med,1996,13:80-83.
  • 4Oswald GA,Smith CC,Betteridge DJ,et al.Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction.Br Med J (Clin Res Ed),1986,293:917-922.
  • 5American Diabetes Association.Screening for type 2 diabetes.Diabetes Care,2004,27 Suppl 1:S11-S14.
  • 6Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Report of the expert committee on the diagnosis and classification of diabetes mellitus.Diabetes Care,2003,26 Suppl 1:S5-S20.
  • 7Gibson CM,Cannon CP,Daley WL,et al.TIMI frame count:a quantitative method of assessing coronary artery flow.Circulation,1996,93:879-888.
  • 8Gibson CM,Cannon CP,Murphy SA,et al.Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.Circulation,2000,101:125-130.
  • 9Matetzky S,Barabash GI,Shahar A,et al.Early T wave inversion after thrombolytic therapy predicts better coronary perfusion:clinical and angiographic study.J Am Coll Cardiol,1994,24:378-383.
  • 10Capes SD,Hunt D,Malmberg K,et al.Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes:a systematic overview.Lancet,2000,355:773-778.

共引文献82

同被引文献40

  • 1张辉,刘金来.妊娠相关血浆蛋白A在冠心病危险分层中的作用[J].国外医学（内科学分册）,2005,32(6):254-257. 被引量：4
  • 2郭雪娅,王琼英,余静.C-反应蛋白与急性冠脉综合征及其干预研究进展[J].心血管病学进展,2006,27(3):315-317. 被引量：8
  • 3黄冰生,程颖,解强,林桂雄,吴钰燕,冯燕玲,李劲草,董吁钢,麦炜颐.冠心病患者血浆纤维蛋白原与冠状动脉病变程度的相关性研究[J].海南医学,2007,18(5):5-6. 被引量：8
  • 4Cavusoglu Y,Gorenek B,Alpsoy S,et al. Evaluation of C-reactive protein,fibrinogen and antithrombin-2 as risk factor for coronary artery disease[J]. Isr Med Assoc J,2001,3:13-16.
  • 5Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardio, 1983,51:606.
  • 6Mulvihill NT,Foley JB. Inflammation in acute coronary syndromes[J]. Heart, 2002,87 ( 3 ) : 201-204.
  • 7Levenson J. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors[J]. Arteriscler Thromb Vasc Biol, 1995,15 :1263 - 1268.
  • 8James A,David A,Janeh,et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes[J]. N Engl J Med,2001,345 : 1014.
  • 9Loeberg M,Tahela R,Harkonen M,et al. Myosin heavy-chain fragments and cardiac troponins in the serum in rhabdomyolysis diagnostic specificity ofnew biochemical markers[J]. Arch Neurol, 1995, 52(12):1210-1214.
  • 10Struthers AD,Davies J. B-type natriuretic peptide: a simple new test to identify coronary artery disease?[J]. QJM,2005,98(10):765 -769.

引证文献5

二级引证文献37

天津医科大学学报
2008年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部